Work

Neoadjuvant Oncogene-Targeted Therapy in Early Stage Non–Small-Cell Lung Cancer as a Strategy to Improve Clinical Outcome and Identify Early Mechanisms of Resistance

Year: 2016

Type: article

Study design: Study Protocol

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2016.05.025

Authors: Caroline E. McCoach, Trever G. Bivona, Collin M. Blakely, Robert C. Doebele

Institutions: University of Colorado Anschutz, University of Colorado Denver, University of California, San Francisco, University of California San Francisco Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: The role of EGFR as a mechanism of therapeutic resistance in gene fusion positive lung cancer., SPORE in Lung Cancer

OpenAlex ID: W2419658677

FWCI: 3.175

Cites: 47

Cited by: 19

Related to: 10